The U.S. and Canadian dollars are frequently in a tug-of-war in the global exchange market. This competitive spirit is mirrored in the magic mushroom industry. Online mushroom dispensaries in Vancouver and other cities are burgeoning. But, can they compete with the rapid advancement of psychedelics in America? Let’s delve into this.
[toc]
Main Takeaways:
- Oregon was the pioneering state to legalize therapeutic use, with licensed professionals facilitating its use.
- In 2020, the Health Minister of Canada authorized four terminally ill cancer patients to use magic mushrooms for end-of-life care.
- Clairvoyant is a 24-week Phase 2 trial at the University of British Columbia studying psilocybin-assisted therapy for adults diagnosed with alcohol use disorder.
The Rapid Growth of the Magic Mushroom Industry in the United States.
The magic mushroom industry in the U.S. has experienced a rapid growth, making it the only drug that competes with cannabis. This accelerated growth points to an increasing societal acceptance of its potential therapeutic benefits.
A Focus on Mental Health
Medical professionals are fascinated by its potential to alleviate symptoms of various mental health conditions, from depression and anxiety to PTSD. Promising results from studies have spurred private pharmaceutical companies to explore its medicinal uses.
This has not only sparked interest in medical applications but has also significantly boosted the economy. Startups and research projects are focusing on the development of psilocybin.
Clinical evidence supporting the use of magic mushrooms in treating certain ailments is growing. NIDA Director Nora Volkow emphasized the increasing evidence that psychedelics have “significant potential” for medical treatments.
Legal Milestones
- Oregon Measure 109: In 2020, Oregon set a precedent by being the first state to legalize psilocybin for therapeutic use, permitting licensed practitioners to administer it.
